Drug intelligence / Profile preview

MicroFlor

Development stage: Unknown
Lead developer: Trifluent Pharma
Modality: Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

MicroFlor is a probiotic pharmaceutical product marketed by Trifluent Pharma, primarily containing *Lactobacillus acidophilus*. It is indicated for the restoration and maintenance of healthy intestinal flora, particularly following the use of antibiotics which can deplete beneficial bacteria. By colonizing the gastrointestinal tract, *Lactobacillus acidophilus* helps suppress the growth of harmful bacteria through the production of lactic acid and hydrogen peroxide, thereby supporting digestive health and preventing conditions such as antibiotic-associated diarrhea. It is typically available as an over-the-counter (OTC) oral supplement.

Brand names: MicroFlor
Other names: Lactobacillus acidophilus

Beyond the preview

Go deeper on MicroFlor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroFlor.

Explore the full profile